Intralytix

company

About

Intralytix is a biotechnology company focused on the discovery, production and marketing.

  • 11 - 50

Details

Last Funding Type
Grant
Industries
Biotechnology,Life Science,Medical
Founded date
Jan 1, 1998
Number Of Employee
11 - 50
Operating Status
Active

Intralytix is a biotechnology company focused on the discovery, production and marketing of bacteriophage-based products to control bacterial pathogens in environmental, food processing, and medical settings. Bacteriophages (bacteria-eater: from the Greek phago meaning "to eat" or "to develop at the expense of") are the most abundant microorganisms on earth. They are the natural enemies of bacteria. Lytic bacteriophages can very effectively kill their targeted specific bacteria without affecting anything else, ensuring an unprecedented level of safety for an antimicrobial.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
Intralytix has raised a total of — in funding over 2 rounds. Their latest funding was raised on May 4, 2020 from a Grant round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
May 4, 2020 Grant 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
Intralytix is funded by 1 investors. National Institutes of Health are the most recent investors.
Investor Name Lead Investor Funding Round
National Institutes of Health Grant